{"id":"https://openalex.org/W4283373583","doi":"https://doi.org/10.1097/01.hs9.0000849184.25255.ba","title":"P1582: CLINICAL CHARACTERISTICS AND INFECTION-RELATED OUTCOMES IN PATIENTS WITH LYMPHOID MALIGNANCIES WITH OR WITHOUT SECONDARY IMMUNODEFICIENCIES: RESULTS FROM A RETROSPECTIVE MULTI-DATABASE STUDY","display_name":"P1582: CLINICAL CHARACTERISTICS AND INFECTION-RELATED OUTCOMES IN PATIENTS WITH LYMPHOID MALIGNANCIES WITH OR WITHOUT SECONDARY IMMUNODEFICIENCIES: RESULTS FROM A RETROSPECTIVE MULTI-DATABASE STUDY","publication_year":2022,"publication_date":"2022-06-01","ids":{"openalex":"https://openalex.org/W4283373583","doi":"https://doi.org/10.1097/01.hs9.0000849184.25255.ba","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9431092"},"language":"en","primary_location":{"id":"doi:10.1097/01.hs9.0000849184.25255.ba","doi":"https://doi.org/10.1097/01.hs9.0000849184.25255.ba","is_oa":true,"landing_page_url":"https://doi.org/10.1097/01.hs9.0000849184.25255.ba","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1097/01.hs9.0000849184.25255.ba","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5063755644","display_name":"Matthew Steven Davids","orcid":"https://orcid.org/0000-0003-4529-2003","observed_orcids":["https://orcid.org/0000-0003-4529-2003"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"M. S. Davids","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019276748","display_name":"Joshua Richter","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4390039328","display_name":"Tisch Cancer Institute","ror":"https://ror.org/0317dzj93","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1320796813","https://openalex.org/I4390039328","https://openalex.org/I98704320"]},{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Richter","raw_affiliation_strings":["Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York","institution_ids":["https://openalex.org/I4390039328","https://openalex.org/I98704320"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046328444","display_name":"Colin Anderson\u2010Smits","orcid":"https://orcid.org/0000-0002-2734-6154","observed_orcids":["https://orcid.org/0000-0002-2734-6154"]},"institutions":[{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C. Anderson-Smits","raw_affiliation_strings":["Takeda Development Center Americas, Inc., Lexington, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Development Center Americas, Inc., Lexington, United States of America","institution_ids":["https://openalex.org/I4210140176"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066006969","display_name":"Marta M. Kamieniak","orcid":"https://orcid.org/0009-0001-9931-2228","observed_orcids":["https://orcid.org/0009-0001-9931-2228"]},"institutions":[{"id":"https://openalex.org/I4405283028","display_name":"Takeda (Poland)","ror":"https://ror.org/00w8t6n25","country_code":"PL","type":"company","lineage":["https://openalex.org/I4405283028","https://openalex.org/I44892455"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"M. Kamieniak","raw_affiliation_strings":["Takeda Pharma Sp.z.o.o., Warsaw, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Pharma Sp.z.o.o., Warsaw, Poland","institution_ids":["https://openalex.org/I4405283028"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041795720","display_name":"K. Ren","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K. Ren","raw_affiliation_strings":["Takeda Development Center Americas, Inc., Lexington, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Development Center Americas, Inc., Lexington, United States of America","institution_ids":["https://openalex.org/I4210140176"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010133869","display_name":"M. Hull","orcid":"https://orcid.org/0000-0001-7414-1576","observed_orcids":["https://orcid.org/0000-0001-7414-1576"]},"institutions":[{"id":"https://openalex.org/I4210108991","display_name":"IQVIA (United States)","ror":"https://ror.org/01mk44223","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108991"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Hull","raw_affiliation_strings":["IQVIA, Falls Church, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IQVIA, Falls Church, United States of America","institution_ids":["https://openalex.org/I4210108991"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088797415","display_name":"J. Multani","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108991","display_name":"IQVIA (United States)","ror":"https://ror.org/01mk44223","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108991"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Multani","raw_affiliation_strings":["IQVIA, Falls Church, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IQVIA, Falls Church, United States of America","institution_ids":["https://openalex.org/I4210108991"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087430965","display_name":"D. Shah","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. Shah","raw_affiliation_strings":["Takeda Development Center Americas, Inc., Lexington, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Development Center Americas, Inc., Lexington, United States of America","institution_ids":["https://openalex.org/I4210140176"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5062219947","display_name":"Csaba Siffel","orcid":"https://orcid.org/0000-0002-6491-6953","observed_orcids":["https://orcid.org/0000-0002-6491-6953"]},"institutions":[{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C. Siffel","raw_affiliation_strings":["Takeda Development Center Americas, Inc., Lexington, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Development Center Americas, Inc., Lexington, United States of America","institution_ids":["https://openalex.org/I4210140176"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5063755644"],"corresponding_institution_ids":["https://openalex.org/I4210117453"],"apc_list":{"value":2480,"currency":"USD","value_usd":2480},"apc_paid":{"value":2480,"currency":"USD","value_usd":2480},"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"6","issue":null,"first_page":"1463","last_page":"1464"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11725","display_name":"Immunodeficiency and Autoimmune Disorders","score":0.5116999745368958,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11725","display_name":"Immunodeficiency and Autoimmune Disorders","score":0.5116999745368958,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":0.4733999967575073,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.004000000189989805,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/secondary-immunodeficiency","display_name":"secondary immunodeficiency","score":0.9229999780654907},{"id":"https://openalex.org/keywords/lymphoid-malignancies","display_name":"lymphoid malignancies","score":0.8970000147819519},{"id":"https://openalex.org/keywords/hypogammaglobulinemia","display_name":"hypogammaglobulinemia","score":0.906000018119812},{"id":"https://openalex.org/keywords/igg-levels","display_name":"IgG levels","score":0.5870000123977661},{"id":"https://openalex.org/keywords/serious-bacterial-infection","display_name":"serious bacterial infection","score":0.8169999718666077},{"id":"https://openalex.org/keywords/infection-related-mortality","display_name":"infection-related mortality","score":0.6800000071525574},{"id":"https://openalex.org/keywords/non-hodgkin-lymphoma","display_name":"non-Hodgkin lymphoma","score":0.8370000123977661},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9340000152587891},{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.984000027179718},{"id":"https://openalex.org/keywords/small-lymphocytic-lymphoma","display_name":"small lymphocytic lymphoma","score":0.9129999876022339},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8339999914169312},{"id":"https://openalex.org/keywords/infection-risk-stratification","display_name":"infection risk stratification","score":0.6349999904632568},{"id":"https://openalex.org/keywords/immunosuppressive-therapy","display_name":"immunosuppressive therapy","score":0.5199999809265137}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8676135540008545},{"id":"https://openalex.org/C2777805810","wikidata":"https://www.wikidata.org/wiki/Q1047559","display_name":"Hypogammaglobulinemia","level":3,"score":0.8283491134643555},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.649312436580658},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5762311220169067},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5405906438827515},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.49413183331489563},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.4506087005138397},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.42196816205978394},{"id":"https://openalex.org/C45827449","wikidata":"https://www.wikidata.org/wiki/Q5270338","display_name":"Diagnosis code","level":3,"score":0.4210923910140991},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2451341152191162},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.20368418097496033},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.15051224827766418},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1097/01.hs9.0000849184.25255.ba","doi":"https://doi.org/10.1097/01.hs9.0000849184.25255.ba","is_oa":true,"landing_page_url":"https://doi.org/10.1097/01.hs9.0000849184.25255.ba","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9431092","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9431092/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hemasphere","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:571fc52edfb64179b8c4e52e0671f2b3","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/571fc52edfb64179b8c4e52e0671f2b3","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"HemaSphere, Vol 6, Pp 1463-1464 (2022)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1097/01.hs9.0000849184.25255.ba","doi":"https://doi.org/10.1097/01.hs9.0000849184.25255.ba","is_oa":true,"landing_page_url":"https://doi.org/10.1097/01.hs9.0000849184.25255.ba","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4379980362","https://openalex.org/W4385667393","https://openalex.org/W4394685093","https://openalex.org/W4385667047","https://openalex.org/W4402494393","https://openalex.org/W4295817047","https://openalex.org/W7117320285","https://openalex.org/W4293087999","https://openalex.org/W4399305498","https://openalex.org/W4405092866"],"abstract_inverted_index":{"Background:":[0],"Patients":[1,143,210],"with":[2,61,80,86,200,211,270,335,374,421,454,480],"lymphoid":[3,62,81,481],"malignancies":[4,63,82,482],"are":[5,47],"at":[6,28,447],"particularly":[7],"high":[8],"risk":[9,30],"of":[10,31,76,155,189,231,239,256,306,356,392,415,424,458,490],"developing":[11,32],"secondary":[12],"immunodeficiencies":[13,215],"(SID).":[14],"Current":[15],"guidelines":[16],"do":[17,38],"not":[18],"provide":[19,40],"an":[20,176],"adequate":[21],"framework":[22],"for":[23,59,117,400,408,452,462],"clinicians":[24],"to":[25,56,123],"identify":[26],"patients":[27,46,60,79,89,193,269,287,334,373,416,453,459,479],"highest":[29],"SID":[33,201,207,212,222,271,289,314,336,344,365,375,384,402,435,455,465,484],"and":[34,74,83,111,135,187,204,303,361,423,483,493],"subsequent":[35],"infections;":[36],"nor":[37],"they":[39,150],"clear":[41],"treatment":[42,428],"pathways":[43],"once":[44],"such":[45],"identified.":[48],"Additional":[49],"data":[50,99],"in":[51,78,88,172,216,310,358,433,438,471],"these":[52],"areas":[53],"may":[54],"help":[55],"optimize":[57],"outcomes":[58,259],"who":[64],"experience":[65],"SID.":[66,91,501],"Aims:":[67],"To":[68],"understand":[69],"the":[70,118,173,217,228,304,351,401,409,434,439],"demographics,":[71],"clinical":[72],"characteristics":[73],"burden":[75,489],"infection":[77,252,340,357,380,422],"SID,":[84],"compared":[85],"those":[87,199,205,342,382,425,463,499],"without":[90,206,288,343,383,464,500],"Methods:":[92],"In":[93,266],"this":[94,475],"observational,":[95],"retrospective":[96],"cohort":[97,403,411,436,441],"study,":[98],"were":[100,147,194,219,272,285,308,350,429],"extracted":[101],"from":[102],"two":[103,197,472],"large":[104,473],"electronic":[105],"record":[106,238],"databases":[107,360],"\u2013":[108,116],"Optum-Humedica":[109],"(H-DB)":[110],"Guardian":[112],"Research":[113],"Network":[114],"(G-DB)":[115],"period":[119,128,133,139],"Oct":[120],"1,":[121],"2015":[122],"Mar":[124],"10,":[125],"2020.":[126],"This":[127],"included":[129,148,179,260,273],"a":[130,136,152,232,237,486],"6-month":[131],"pre-index":[132],"(PIP)":[134],"12-month":[137,327],"follow-up":[138],"following":[140],"patient":[141,301],"identification.":[142],"aged":[144],"\u226518":[145],"years":[146],"if":[149],"had":[151,337],"confirmed":[153],"diagnosis":[154,180],"chronic":[156],"lymphocytic":[157,160],"leukemia":[158],"(CLL)/small":[159],"lymphoma":[161,168],"(SLL),":[162],"multiple":[163],"myeloma":[164],"(MM)":[165],"or":[166,213,236,278,294],"non-Hodgkin":[167],"(NHL;":[169],"H-DB":[170],"only)":[171],"PIP.":[174],"Using":[175],"algorithm":[177],"that":[178,478],"codes,":[181],"immunoglobulin":[182],"G":[183],"(IgG)":[184],"serum":[185,243],"levels":[186],"presence":[188],"key":[190],"infections/treatments,":[191],"eligible":[192],"stratified":[195],"into":[196],"cohorts:":[198],"(SID":[202],"cohort)":[203],"(no-SID":[208],"cohort).":[209],"primary":[214,247],"PIP":[218],"excluded.":[220],"The":[221,246,413],"index":[223],"date":[224],"was":[225,249,396,450],"defined":[226],"as":[227,284],"first":[229],"occurrence":[230],"hypogammaglobulinemia":[233],"ICD-10":[234],"code,":[235],"low":[240],"(<5.0":[241],"g/L)":[242],"IgG":[244],"levels.":[245],"outcome":[248],"severe":[250,378,393],"bacterial":[251,379,394],"over":[253],"12":[254],"months":[255,449],"follow-up.":[257],"Secondary":[258],"overall":[261,496],"survival":[262,446,497],"(Kaplan\u2013Meier":[263],"analysis).":[264],"Results:":[265],"total,":[267],"2,221":[268],"(H-DB/G-DB:":[274,290,456],"n=1,959/262":[275],"[25.6%/33.6%":[276],"CLL":[277,293],"SLL,":[279,295],"44.4%/66.4%":[280],"MM,":[281,297],"30.0%/0%":[282],"NHL]),":[283],"19,141":[286],"n=17,598/1,543":[291],"[22.3%/50.2%":[292],"21.4%/49.8%":[296],"56.3%/0%":[298],"NHL]).":[299],"Mean":[300],"age":[302],"proportion":[305],"men":[307],"similar":[309],"both":[311,330,359],"cohorts":[312,363],"(H-DB/G-DB":[313,364],"cohort:":[315,321,366,369],"67.3/70.6":[316],"years,":[317],"54.8%/56.1%":[318],"men;":[319],"no-SID":[320,368,410,440],"67.9/72.2":[322],"years;":[323],"52.8%/53.6%":[324],"men).":[325],"At":[326],"follow-up,":[328],"across":[329,362],"databases,":[331,474],"significantly":[332,431,487],"more":[333,372],"experienced":[338,376],"\u22651":[339,377,418],"than":[341,381,437,461,498],"(both":[345,385,442],"p<0.001;":[346,443],"Table).":[347,444],"Bacterial":[348],"infections":[349,395],"most":[352],"frequently":[353],"reported":[354],"type":[355],"55.1%/54.6%;":[367],"24.0%/25.7%).":[370],"Significantly":[371],"p<0.001);":[386],"H-DB/G-DB":[387],"mean":[388],"(standard":[389],"deviation)":[390],"number":[391],"7.6":[397],"(9.9)/2.9":[398],"(2.7)":[399],"versus":[404],"5.2":[405],"(6.8)/2.4":[406],"(2.2)":[407],"(Table).":[412],"proportions":[414],"experiencing":[417],"hospitalization":[419],"associated":[420],"using":[426],"anti-infective":[427],"also":[430],"greater":[432],"Overall":[445],"24":[448],"lower":[451],"76.3%/77.3%":[457],"alive)":[460],"(86.9%/87.8%).":[466],"Image:Summary/Conclusion:":[467],"With":[468],"comparable":[469],"results":[470],"study":[476],"confirms":[477],"face":[485],"higher":[488],"infectious":[491],"complications":[492],"have":[494],"shorter":[495]},"counts_by_year":[],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2022-06-25T00:00:00"}